News for Investigators

The National Institute for Health Research Clinical Research Network (NIHR CRN) is planning changes to its organisational structure, with the Central and East London region (in which UCLH is based) as the pilot region for these changes. In a bid to simplify geographies and enhance the delivery of

Sir Paul Nurse, Director of the Francis Crick Institute, unveiled the organisation’s strategy today at a ceremony attended by senior government ministers and heads of the institute's founding partners, including UCL's President & Provost Professor Malcolm Grant.

A number of board and panel vacancies are available at the NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC). These openings are for funding board members, panel members and panel chairs for the following health research programmes: Efficacy and Mechanism Evaluation (EME) Programme

Research Design Service (RDS) London is hosting a series of drop-in clinics for researchers in South London in May and June. If you are planning to submit an application to get health and social care research funding or would just like to find out more this is a free event and there is no

The UCLH Innovation Office has extended its call for ideas from UCLH staff for solving problems involving equipment and improving patient care. Ideas are particularly welcomed that can be used in other trusts, primary care or community settings. These can be ideas used in a pilot study already, or

Latest funding news includes call from the Health Innovation Challenge Fund (HIC Fund) for applications and new dates for the i4i Life Science Accelerator programme. The Health Innovation Challenge Fund (HIC Fund) The HIC Fund is inviting applications for funding in five key areas, with each funding

The UCLH Innovation Office has put a call out for ideas from UCLH staff for solving problems involving equipment and improving patient care. We particularly welcome ideas that can be used in other trusts, primary care or community settings.

Professor Henning Walczak and his team have joined the UCL Cancer Institute. His team, which is funded by Cancer Research UK, the Wellcome Trust, the European Research Council, the Biotechnology and Biological Sciences Research Council and the Association for International Cancer Research, is internationally recognised for its work on cell death and inflammation, specifically focussing on the biology of death receptor-ligand and the ubiquitin systems.